American Oriental Bioengineering, Inc.
AOBI · OTC
9/30/2013 | 6/30/2013 | 3/31/2013 | 12/31/2012 | |
|---|---|---|---|---|
| Revenue | $17,936 | $20,224 | $21,007 | $62,414 |
| % Growth | -11.3% | -3.7% | -66.3% | – |
| Cost of Goods Sold | $14,829 | $15,238 | $16,506 | $35,387 |
| Gross Profit | $3,108 | $4,986 | $4,501 | $27,027 |
| % Margin | 17.3% | 24.7% | 21.4% | 43.3% |
| R&D Expenses | $3,245 | $1,723 | $1,407 | $1,268 |
| G&A Expenses | $9,498 | $11,018 | $12,477 | $13,678 |
| SG&A Expenses | $14,984 | $13,727 | $16,122 | $19,185 |
| Sales & Mktg Exp. | $5,487 | $2,708 | $4 | $5,508 |
| Other Operating Expenses | $3,851 | -$143 | $5,990 | $5,040 |
| Operating Expenses | $22,081 | $15,306 | $21,157 | $25,493 |
| Operating Income | -$18,973 | -$10,320 | -$19,018 | -$29,825 |
| % Margin | -105.8% | -51% | -90.5% | -47.8% |
| Other Income/Exp. Net | -$1,945 | -$1,822 | -$4,107 | -$35,597 |
| Pre-Tax Income | -$20,918 | -$12,142 | -$20,764 | -$35,120 |
| Tax Expense | $259 | $699 | $351 | $783 |
| Net Income | -$21,177 | -$12,841 | -$21,115 | -$35,886 |
| % Margin | -118.1% | -63.5% | -100.5% | -57.5% |
| EPS | -290.36 | -176.28 | -288.69 | -485.66 |
| % Growth | -64.7% | 38.9% | 40.6% | – |
| EPS Diluted | -290.36 | -176.28 | -288.69 | -485.66 |
| Weighted Avg Shares Out | 73 | 73 | 73 | 74 |
| Weighted Avg Shares Out Dil | 73 | 73 | 73 | 74 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $898 | $1,003 | $764 | $860 |
| Depreciation & Amortization | $2,965 | $2,900 | $3,035 | $3,074 |
| EBITDA | -$16,008 | -$7,234 | -$16,965 | -$31,187 |
| % Margin | -89.3% | -35.8% | -80.8% | -50% |